An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Some experts said the popularity for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.
Platform Response and Content Removal
According to TikTok, the platform has taken down violative material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform safe and allocating resources in enhancing compliance measures.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.
After minutes of joining one group, a vendor posted contact information, where most purchases occur. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Item Details and Costs
Inside these communities, messages display black plastic parcels with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service said it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose users to potentially significant medical dangers”.
